secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2024-12-03T23:59:59+00:00
Accession:  0001493152-24-048497
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce Biosciences announces 1-for-15 reverse stock split effective Dec 6, 2024
--------------------------------------------------------------------------------

- Reverse stock split at 1-for-15 ratio, effective 12:01 am on December 6, 2024.
- Stockholders approved range of 1:10 to 1:40; board selected 1:15 ratio.
- No fractional shares issued; fractional shares rounded up to nearest whole share.
- Proportionate adjustments to warrants, stock options, and RSUs will be made.
- New CUSIP number for post-split common stock is 293602504.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224048497/0001493152-24-048497-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315224048497/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-048497

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer